Multidimensional fatigue in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: incidence, severity, and risk factors

• Published in: Supportive care in cancer 2021-09, Vol.29 (9), p.5009-5019
• Main Authors: Chen, Lin-Min, Yang, Qiu-Lan, Duan, Yu-Yu, Huan, Xue-Zhen, He, Yan, Wang, Cong, Fan, Yu-Ying, Cai, Yu-Cong, Li, Jian-Mei, Chen, Li-Ping, Qin, Hui-Ying
• Format: Article
• Language: English
• Subjects: Body mass index; Cancer; Carcinoma; Care and treatment; Chemotherapy; Fatigue; Head & neck cancer; Lymphocytes; Medical research; Medicine; Medicine & Public Health; Medicine, Experimental; Nursing; Nursing Research; Oncology; Original Article; Pain Medicine; Radiation therapy; Rehabilitation Medicine; Risk factors; Throat cancer
• ISSN: 0941-4355; 1433-7339
• DOI: 10.1007/s00520-021-06054-7

Purpose To explore the incidence, severity, and risk factors of multidimensional fatigue in patients with nasopharyngeal carcinoma (NPC) receiving concurrent chemoradiotherapy (CCRT). Methods This prospective study included 79 patients with NPC in Guangzhou (China) from June 2015 to July 2018. Data were collected before and after CCRT, including demographic and clinical characteristics, nutritional parameters, and fatigue scores, based on completion of the Multiple Dimensional Inventory-20 Questionnaire, with five subscales: General Fatigue, Mental Fatigue, Physical Fatigue, Reduced Activity, and Reduced Motivation. Results Increased general fatigue was found to be associated with lower lymphocyte count and body mass index 42 years. Higher scores for reduced activity were associated with age > 42 years, female sex, and lower serum sodium. Increased mental fatigue was related with lower lymphocyte count and unemployment; and increased total fatigue was associated with lower lymphocyte count, age > 42 years, and 3–6 courses of treatment. Furthermore, 3–6 courses of treatment was an independent predictor of severe general fatigue, while age >42 years was an independent predictor of severe physical fatigue. Importantly, cancer stage IVB and 3–6 courses of treatment could predict severe total fatigue. Conclusions Our data demonstrate that fatigue is increased in all dimensions in NPC patients following CCRT, and that the predictors differ for each fatigue dimension. These results could guide the development of targeted interventions that may reduce the impact of cancer-related fatigue in patients with NPC.